CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance... Show more
CNA Financial Corporation has navigated a volatile stretch in the commercial property and casualty insurance landscape, with its stock delivering a modest gain of roughly 2.5% over the trailing 30 days. Shares closed at $52.47 on July 31, 2026, retreating from the 52-week high of $55.71 reached on July 28. The pullback reflects a market recalibrating expectations heading into the company's second-quarter earnings release. Broader sentiment in the P&C insurance sector remains mixed: while property lines have stabilized after years of rate hardening, casualty and liability segments face persistent headwinds from social inflation and elevated claims costs. CNA trades at a forward price-to-earnings multiple of approximately 12.8, a discount to broader financial sector averages, and its beta of 0.28 signals low correlation to broader equity market swings — characteristic of a stable, income-oriented holding.
CNA Financial Corporation is one of the largest commercial property and casualty insurers in the United States, with a heritage spanning more than 125 years. Headquartered in Chicago, Illinois, and majority-owned by Loews Corporation, CNA operates through three primary segments: Specialty, Commercial, and International, alongside a legacy Life & Group runoff business. The Specialty segment provides management and professional liability, cyber coverage, and healthcare liability products distributed through brokers and independent agencies. The Commercial segment targets small businesses, middle-market firms, and construction clients with property, workers' compensation, general liability, and commercial auto insurance. Internationally, CNA underwrites through operations in Canada, the United Kingdom, and Continental Europe, including its Lloyd's syndicate. With approximately 6,600 employees and trailing twelve-month revenue exceeding $15 billion, CNA competes against carriers such as AFG, ORI, and THG, differentiating itself through specialized underwriting expertise and a conservative investment approach anchored by high-quality fixed-income securities.
The most consequential event shaping CNA's near-term narrative is the upcoming Q2 2026 earnings report on August 3. This follows a challenging first quarter reported on May 4, where core income of $225 million translated to EPS of $0.83 — a substantial miss against the $1.30 consensus. The shortfall stemmed from deliberate reserve strengthening in two areas: excess casualty within the Commercial segment and professional errors-and-omissions coverage within Specialty lines. Management characterized the action as prudent given ongoing social inflation and adverse loss trends. The reserve charge added 4.1 percentage points to the P&C combined ratio, pushing the all-in figure to 102.2%, while the underlying combined ratio rose to 94.5% from 92.1% a year earlier.
On a more positive note, net investment income held steady at $610 million, supported by a consolidated fixed-income effective yield of 4.9%. The company continued to advance over 100 discrete AI initiatives spanning claims summarization, risk control analytics, and underwriting workflows — an efficiency strategy increasingly common across the insurance industry. Meanwhile, global commercial insurance rates fell 6% during the second quarter, intensifying competitive pressures on premium growth. CNA posted only 1% net written premium growth in Q1 with 83% retention, though middle-market Commercial and International segments showed stronger momentum. The company declared its regular quarterly dividend of $0.48 per share in May, maintaining a yield above 3.6%. On the ratings front, Weiss Ratings upgraded CNA from Hold to Buy in late June, while Zacks Research reiterated a Strong Sell designation and DOWLING & PARTNERS raised its full-year 2026 EPS estimate to $4.10.
Tickeron's Trending AI Robots page offers traders and investors a curated view into a vast ecosystem of AI-driven trading strategies. With hundreds of automated bots actively trading thousands of tickers across equity markets, the platform filters for top-performing and most relevant strategies, giving users a streamlined entry point into algorithmic trading. Each bot follows a distinct methodology — some optimized for short-term momentum, others designed around swing trading or longer-duration trend following — and is accompanied by transparent performance metrics. Whether you are exploring systematic approaches for stocks like CNA or scanning for strategies across sectors, the Trending AI Robots section provides a continuously updated snapshot of what quant-driven intelligence looks like in today's markets.
Looking ahead, several factors will define CNA's trajectory through the remainder of 2026. The immediate focus is on second-quarter results and whether management signals that prior reserve actions have adequately addressed casualty exposure, or if additional strengthening is required. Commentary on loss cost trends — which management estimates modestly above 7% — and the trajectory of the underlying combined ratio will be critical. The competitive pricing environment, with global commercial rates declining 6%, adds pressure to sustain premium growth without sacrificing underwriting discipline. Additionally, the interest rate backdrop remains a double-edged sword: while higher-for-longer rates boost fixed-income portfolio yields, they may also dampen economic activity and commercial insurance demand. CNA's technology investments, including its expanding suite of AI tools, could provide operational leverage over time, though near-term benefits remain incremental. Finally, any changes in Loews Corporation's strategic posture toward its majority-owned subsidiary would represent a significant catalyst. With a forward P/E near 12.8 and a dividend yield comfortably above 3.5%, CNA offers an income-oriented profile, but investors must weigh that against ongoing casualty reserve uncertainty and a softening rate environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Oscillator for CNA moved out of overbought territory on July 30, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on August 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNA as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CNA turned negative on July 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CNA broke above its upper Bollinger Band on July 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNA advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 233 cases where CNA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.237) is normal, around the industry mean (2.134). P/E Ratio (11.267) is within average values for comparable stocks, (15.668). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.072). Dividend Yield (0.037) settles around the average of (0.023) among similar stocks. P/S Ratio (0.937) is also within normal values, averaging (1.588).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of property, casualty, and health insurance products and services
Industry PropertyCasualtyInsurance